Ontology highlight
ABSTRACT: Background
Cinnamon has been studied as a possible way to control blood glucose and serum cholesterol levels. However, there are no well-conducted randomized controlled trials that can accurately measure the lipid and glucose-lowering effects of Cinnamomum zeylanicum (C. zeylanicum) extract. This study primarily aimed to evaluate the effect of a standardized C. zeylanicum extract on serum low-density lipoprotein cholesterol (LDL-C) levels and secondarily on other lipid parameters (high-density lipoprotein cholesterol (HDL-C), total cholesterol and triglycerides), glucose levels, anthropometric measures, blood pressure, and safety outcomes in individuals with an LDL level between 100-190mg/dL.Materials and methods
This was a randomized, double-blinded, placebo-controlled cli
SUBMITTER: Muthukuda D
PROVIDER: S-EPMC11759401 | biostudies-literature | 2025
REPOSITORIES: biostudies-literature